90 related articles for article (PubMed ID: 3706982)
41. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
[TBL] [Abstract][Full Text] [Related]
42. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
[TBL] [Abstract][Full Text] [Related]
43. [Home anti-cancer therapy with a venous port].
Muto A; Ashino Y; Miyazawa M; Sato M; Kanno A; Kawahara Y; Fujita Y; Matsushiro T
Gan To Kagaku Ryoho; 2000 Dec; 27 Suppl 3():619-22. PubMed ID: 11190304
[TBL] [Abstract][Full Text] [Related]
44. Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma.
Sekine I; Nokihara H; Horiike A; Yamamoto N; Kunitoh H; Ohe Y; Tamura T; Kodama T; Saijo N
Br J Cancer; 2004 Mar; 90(6):1125-8. PubMed ID: 15026789
[TBL] [Abstract][Full Text] [Related]
45. [Preliminary clinical evaluation of continuous infusion of 5-FU and low-dose Cisplatin (LFP) therapy alone and combined with radiation therapy for treatment of advanced or recurrent esophageal cancer].
Itoh S; Morita S; Ohnishi T; Tsuji A; Takamatsu M; Horimi T
Gan To Kagaku Ryoho; 2002 Feb; 29(2):233-8. PubMed ID: 11865629
[TBL] [Abstract][Full Text] [Related]
46. An active chemotherapy regimen for squamous cell lung cancer.
Cohen MH; Johnston-Early A; Citron ML; Krasnow SH; Fossieck BE
Cancer Treat Rep; 1984 Mar; 68(3):475-9. PubMed ID: 6200219
[TBL] [Abstract][Full Text] [Related]
47. Intraoperative chemohyperthermia in the management of digestive cancers. A general review of literature.
Sayag AC; Gilly FN; Carry PY; Perdrix JP; Panteix G; Brachet A; Banssillon V; Braillon G
Oncology; 1993; 50(5):333-7. PubMed ID: 8378027
[TBL] [Abstract][Full Text] [Related]
48. Intraperitoneal chemotherapy for patients with advanced epithelial ovarian cancer: a review of complications and completion rates.
Landrum LM; Gold MA; Moore KN; Myers TK; McMeekin DS; Walker JL
Gynecol Oncol; 2008 Feb; 108(2):342-7. PubMed ID: 17988721
[TBL] [Abstract][Full Text] [Related]
49. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
[TBL] [Abstract][Full Text] [Related]
50. [Combination chemotherapy with nedaplatin and 5-fluorouracil for oral squamous cell carcinomas].
Yamaoka K; Fukuda M; Kuwajima S; Hagiwara H; Toshima S; Matsuoka A; Ohnuki T; Seki H; Nagai H; Iino M; Sageshima M
Gan To Kagaku Ryoho; 2003 Jul; 30(7):951-5. PubMed ID: 12894709
[TBL] [Abstract][Full Text] [Related]
51. Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
Rivera F; Vega-Villegas ME; López-Brea M; Isla D; Mayorga M; Galdós P; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Mayordomo J; Rama J; Saiz-Bustillo R; Sanz-Ortiz J
Cancer Chemother Pharmacol; 2008 Jul; 62(2):253-61. PubMed ID: 17901953
[TBL] [Abstract][Full Text] [Related]
52. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
53. [Concomitant radiotherapy and chemotherapy with protracted low dose continuous infusion of 5-fluorouracil and cisplatin].
Sueyama H; Sakai K; Hasegawa M; Tsuchida E; Ito T; Sugita T; Higuchi S; Fujita K
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2839-41. PubMed ID: 7993125
[No Abstract] [Full Text] [Related]
54. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
Uekado Y; Ogawa T; Yoshida T; Yamamoto S; Hirano A; Watanabe T; Shinka T; Ohkawa T
Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
[TBL] [Abstract][Full Text] [Related]
55. Nursing--serving for the society (the establishment of outpatient nursing advisory and home care services in Shanghai, China).
Bao WJ
Oncol Nurs Forum; 1987; 14(6):63-5. PubMed ID: 3697292
[No Abstract] [Full Text] [Related]
56. Home infusion for the 1990s: a patient's perspective.
Freeman FL
N J Med; 1992 Jan; 89(1):60-2. PubMed ID: 1542455
[TBL] [Abstract][Full Text] [Related]
57. A direct assault on abdominal cancers.
McVey L
RN; 1992 Feb; 55(2):46-52. PubMed ID: 1546254
[No Abstract] [Full Text] [Related]
58. [Value of chemotherapy in cancers of the upper respiratory tract. Indications and limited hops].
Gehanno P
Rev Prat; 1992 Jan; 42(2):201-3. PubMed ID: 1566002
[No Abstract] [Full Text] [Related]
59. Reaffirming catheter placement and patency.
Erickson K; DeBuque SM
Oncol Nurs Forum; 1986; 13(4):14-5. PubMed ID: 3636908
[No Abstract] [Full Text] [Related]
60. Cancer chemotherapy by constant infusion.
Lokich JJ
Hosp Pract (Off Ed); 1983 Nov; 18(11):50c, 50H, 50J, passim. PubMed ID: 6414939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
